EV Biologics (YECO) Stock Price, News & Analysis $0.99 0.00 (0.00%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$0.99▼$0.9950-Day Range$0.70▼$1.5052-Week Range$0.70▼$2.34Volume100 shsAverage Volume1,243 shsMarket Capitalization$10.13 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest About EV Biologics Stock (OTCMKTS:YECO)EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.Read More YECO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart YECO Stock News HeadlinesDecember 1, 2023 | americanbankingnews.comEV Biologics, Inc. (OTCMKTS:YECO) Sees Large Drop in Short InterestOctober 17, 2023 | reuters.comChinese EV startup WM Motor files for pre-restructuringDecember 11, 2023 | Edge On The Street (Ad)U.S. Military Defense Fails Without Vanadium?The metal vanadium is needed for numerous military applications, including jet engines, airframes, and ballistic missiles. And although the U.S. Govt. considers vanadium critical to national security, less than 5% of the metal is mined in America. This means we're at the mercy of China and Russia for our supply. October 4, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Updates on Funding and SalesOctober 2, 2023 | finance.yahoo.comEV Biologics Updates on Funding and SalesAugust 16, 2023 | finance.yahoo.comEV Biologics Completes Production of Cutting-Edge MSC Exosome-Based TherapeuticAugust 7, 2023 | finance.yahoo.comEV Biologics Appoints Senior Investment Banker as Corporate Finance DirectorAugust 3, 2023 | money.usnews.comHow the New EV Tax Credit Will Affect Your Auto LoanDecember 11, 2023 | Edge On The Street (Ad)U.S. Military Defense Fails Without Vanadium?The metal vanadium is needed for numerous military applications, including jet engines, airframes, and ballistic missiles. And although the U.S. Govt. considers vanadium critical to national security, less than 5% of the metal is mined in America. This means we're at the mercy of China and Russia for our supply. August 2, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Hires Senior Chief Financial OfficerAugust 2, 2023 | finance.yahoo.comEV Biologics Hires Senior Chief Financial OfficerJuly 30, 2023 | news.yahoo.comToyota is planning a new EV with a 900-mile range and 10-minute charging time: ‘The holy grail of battery vehicles’July 16, 2023 | usatoday.comAre you a gas guzzler? The government might try to persuade you to switch to an EVJune 21, 2023 | usatoday.comHow reliable are public EV charging stations? Report shows many EV drivers have issuesMay 27, 2023 | finance.yahoo.comEV Biologics, Inc. (YECO)May 17, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Signs Exclusive Distribution Agreement for South AmericaMay 15, 2023 | finance.yahoo.comEV Biologics Signs Exclusive Distribution Agreement for South AmericaMay 11, 2023 | benzinga.comBest EV Penny StocksApril 30, 2023 | washingtonpost.comGM to scrap Chevy Bolt, its most popular and least expensive EVMarch 19, 2023 | a.msn.comTesco EV charging network reaches 600 UK stores – and rapid chargers go liveFebruary 21, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Generates Mesenchymal Stem Cell LinesFebruary 21, 2023 | finance.yahoo.comEV Biologics Generates Mesenchymal Stem Cell LinesJanuary 3, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Updates on Excyte Subsidiary FundingJanuary 3, 2023 | finance.yahoo.comEV Biologics Updates on Excyte Subsidiary FundingJanuary 2, 2023 | cnet.comThe Best Tires for Your EV Have 4 Unique ChallengesNovember 16, 2022 | finanznachrichten.deEV Biologics Corporation: EV Biologics Initiates PCAOB Audit to Seek Uplift to OTCQXNovember 14, 2022 | finance.yahoo.comEV Biologics Initiates PCAOB Audit to Seek Uplift to OTCQXSee More Headlines Receive YECO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EV Biologics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today12/11/2023Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Concrete, gypsum, & plaster products Sub-IndustryN/A SectorConstruction Current SymbolOTCMKTS:YECO CUSIPN/A CIK1607741 Webwww.evbiologics.com Phone(518) 638-8192FaxN/AEmployees284Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares10,230,000Free Float6,006,000Market Cap$10.13 million OptionableNot Optionable Beta0.05 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Daniel S. McKinney (Age 61)Founder, Chairman & CEO Mr. Monte FisherChief Financial OfficerMr. William BossungCorporate Finance Director & Corporate SecretaryKey CompetitorsENGlobalNASDAQ:ENGWilliams Industrial Services GroupOTCMKTS:WLMSAenza S.A.A.NYSE:AENZWANG & LEE GROUPNASDAQ:WLGSEnergy FocusNASDAQ:EFOIView All Competitors YECO Stock Analysis - Frequently Asked Questions How have YECO shares performed in 2023? EV Biologics' stock was trading at $1.70 at the beginning of 2023. Since then, YECO stock has decreased by 41.8% and is now trading at $0.99. View the best growth stocks for 2023 here. Are investors shorting EV Biologics? EV Biologics saw a decline in short interest in November. As of November 15th, there was short interest totaling 1,900 shares, a decline of 17.4% from the October 31st total of 2,300 shares. Based on an average trading volume of 300 shares, the days-to-cover ratio is currently 6.3 days. View EV Biologics' Short Interest. How do I buy shares of EV Biologics? Shares of YECO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:YECO) was last updated on 12/11/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EV Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.